Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis

Obesity and Prostate Cancer: Weighing the Evidence

(2012) Emma H. Allott et al.   EUROPEAN UROLOGY

Safety and tolerability of intermittent androgen deprivation therapy: A literature review

(2012) Damian Gruca et al.   INTERNATIONAL JOURNAL OF UROLOGY

Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer

(2012) Philip J. Saylor et al.   JOURNAL OF UROLOGY

Syndrome métabolique et insulinorésistance chez les patients atteints de cancer de la prostate traités par suppression androgénique hormonale

(2012) J.-E. Terrier et al.   PROGRES EN UROLOGIE

Prostate Cancer, Androgen Deprivation Therapy, Obesity, the Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease

(2011) Andrew Collier et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks

(2011) Juan-Jie Bo et al.   ASIAN JOURNAL OF ANDROLOGY

Testosterone, cardiovascular disease and the metabolic syndrome

(2011) Giovanni Corona et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

1095 PREVALENCE OF METABOLIC SYNDROME IN PROSTATE CANCER PATIENTS UNDER ANDROGEN DEPRIVATION THERAPY: INTERIM RESULTS OF A CASE-CONTROL STUDY

(2011) J. Ropero Valverde et al.   EUROPEAN UROLOGY SUPPLEMENTS

Metabolic sequelae associated with androgen deprivation therapy for prostate cancer

(2011) Jason E Faris et al.   Current Opinion in Endocrinology Diabetes and Obesity

Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden

(2010) Mieke Van Hemelrijck et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden

(2010) Mieke Van Hemelrijck et al.   LANCET ONCOLOGY

The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis

(2010) Farhana Haseen et al.   Journal of Cancer Survivorship

Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome

(2009) G. Corona et al.   Aging Male

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

(2009) Lockwood G. Taylor et al.   CANCER

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases

(2009) G. Corona et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

(2009) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer

(2008) Christopher J. DiBlasio et al.   BJU INTERNATIONAL

Metabolic and cardiovascular effects of androgen deprivation therapy

(2008) Payam Hakimian et al.   BJU INTERNATIONAL

Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis

(2008) Sadeka Shahani et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM